郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.

期刊:The Journal of pharmacology and experimental therapeutics发表年份:2007作者:Takuma Mihara; Kayoko Mihara; Junko Yarimizu; Yasuyuki Mitani; Ritsuko Matsuda; Hiroko Yamamoto; Satoshi Aoki; Atsushi Akahane; Akinori Iwashita; Nobuya Matsuoka

药效评价F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. I. In vitro receptor affinity and efficacy profile.

期刊:British journal of pharmacology发表年份:2007作者:A Newman-Tancredi; M-B Assié; J-C Martel; C Cosi; L Bruins Slot; C Palmier; I Rauly-Lestienne; F Colpaert; B Vacher; D Cussac

药效评价Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.

期刊:The Journal of pharmacology and experimental therapeutics发表年份:2007作者:Narender R Gavva; Anthony W Bannon; David N Hovland; Sonya G Lehto; Lana Klionsky; Sekhar Surapaneni; David C Immke; Charles Henley; Leyla Arik; Annette Bak; James Davis; Nadia Ernst; Gal Hever; Rongzhen Kuang; Licheng Shi; Rami Tamir; Jue Wang; Weiy

药效评价Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells.

期刊:Pharmacological research发表年份:2007作者:Stefano Bellosta; Roberta Baetta; Monica Canavesi; Carmen Comparato; Agnese Granata; Mara Monetti; Fausto Cairoli; Ivano Eberini; Lina Puglisi; Alberto Corsini